Norris Medicines Board Meeting on 14th Nov'26 to Consider Q2 Results
Norris Medicines Ltd 路 Intimation 路 14 Nov 2026, 5:30 am
Norris Medicines Board Meeting on 14th Nov'26 to Consider Q2 Results Norris Medicines Limited has scheduled a Board of Directors meeting on 14th Nov'26 to consider and approve the unaudited financial results and Limited Review Report for the quarter and half-year ended 30th Sep'26. Additionally, the trading window for dealing in company securities has been closed since 1st Oct'26 and will reopen 48 hours after the declaration of the financial results.
Original exchange filing (PDF)
More announcements from Norris Medicines Ltd
- Un-audited financial results for the quarter and half year ended 30th September, 2026 路 14 Nov 2026
- Outcome Of Board Meeting Held Today I.E. Saturday, November 14, 2026 路 14 Nov 2026
- Scrutinizer''s Report and Voting Results of the 35th Annual General Meeting of the Company held on Tuesday 29th September, 2026 路 30 Sept 2026
- Scrutinizer''s Report and Voting Results of the 35th Annual General Meeting of the Company held on Tuesday 29th September, 2026 路 30 Sept 2026
- Outcome and proceeding of the 35th Annual General Meeting of the Company held on Tuesday 29th September, 2026 路 29 Sept 2026
- Outcome and proceeding of the 35th Annual General Meeting of the Company held on Tuesday 29th September, 2026 路 29 Sept 2026
- Outcome of 35th Annual General Meeting of the Company held on Tuesday, 29th September, 2026 路 29 Sept 2026
- Annual Report of the Company for the Financial year 2025-26. 路 05 Sept 2026
